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Abstract This study investigated the effects of 
myofilament carbonylation in permeabilized human 
left ventricular cardiomyocytes. Protein 
carbonylation was monitored by the oxyblot 
method following the in vitro application of the 
Fenton reaction reagents [iron(II), ascorbic acid and 
hydrogen peroxide (H2O2)], known to produce 
hydroxyl radicals. Sulfhydryl group oxidation was 
assessed in parallel by the Ellman assay. During 
force measurements, the Ca2+-activated active force, 
the Ca2+-independent passive force and the Ca2+ 
sensitivity of force production (pCa50) were 
measured in permeabilized cardiomyocytes before 
and after in vitro carbonylation. Carbonylation at the 
levels of several myofilament proteins (e.g. myosin 
heavy chain, α-actinin, actin, myosin binding 
protein C, desmin and myosin light chain 1) was 
enhanced by increasing concentrations of H2O2 (0-
105 µM) in the Fenton solution. Carbonylation 
suspended active force generation following 
aggressive Fenton treatment (105 µM H2O2), 
whereas the application of 3*103 µM H2O2 decreased 
pCa50 (from 5.74±0.01 to 5.65±0.01; mean±SEM, 
P<0.05) and increased the passive force (from 
1.72±0.21 kN/m2 to 2.33±0.22 kN/m2). None of these 
changes was influenced by sulfhydryl group 
reduction. Thus, myofilament carbonylation 
dysregulates the contractile function in human 
cardiomyocytes, and may therefore mediate the 
contractile dysfunction during oxidative stress. 
Keywords: carbonylation, isolated human 
cardiomyocytes, contractile function, oxidative 
stress 
 
1. Introduction 
 
Oxidative stress, a state characterized by excessively 
produced reactive oxygen and/or nitrogen species 
(ROS/RNS), plays a central role in the pathogenesis 
of various cardiovascular diseases, including 
chronic heart failure [1,2], post-infarction 
remodeling [3] and diabetic cardiomyopathy [4]. 
ROS/RNS induce oxidative protein 
modifications at different subcellular levels, e.g. in 
the myofilaments, resulting in a contractile 
dysfunction. Protein carbonylation, one of the most 
commonly used biomarkers of severe oxidative 
stress [5], is an irreversible oxidative modification 
that develops when reactive aldehydes or ketones 
undergo addition to amino acid residues [6]. 
Primary protein carbonylation occurs in metal-
catalyzed oxidation on proline, arginine, lysine and 
threonine residues [7], whereas a secondary 
mechanism involves the addition of reactive lipid 
aldehydes to proteins [8,9]. Metal-catalyzed 
oxidation results in the production of hydroxyl 
radicals through the participation of hydrogen 
peroxide (H2O2) and iron(II) cations in the Fenton 
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reaction [10,11], where hydroxyl radical production 
can be confirmed by electron paramagnetic/spin 
resonance spectroscopy [12]. Additionally, this 
system is widely used for the in vitro induction and 
investigation of protein carbonylation [13]. 
Protein carbonylation has been implicated as a 
pathogenic factor in diabetic cardiomyopathy [14], 
in myocardial ischemia [15], during reperfusion 
following ischemia [16], after coronary 
microembolization [17] and in human heart failure 
[18]. Protein carbonylation can modulate the 
function of the carbonylated proteins, and can 
therefore interfere with the activity of signaling 
molecules such as annexin or peroxiredoxin [8]. 
However, few data are available as concerns how 
myofilament protein carbonylation modulates the 
contractile function of a single cardiomyocyte in the 
human heart. 
In the present study, Fenton chemistry (in 
which iron(II), H2O2 and ascorbic acid participate) 
was used to induce the in vitro protein 
carbonylation of human myofibrillar proteins. 
Functional consequences of this oxidative 
modification were tested in isometric force 
measurements in isolated permeabilized left 
ventricular cardiomyocytes. Fenton reaction-
derived hydroxyl radicals increased the degree of 
contractile protein carbonylation in parallel with a 
decline in Ca2+-dependent active isometric force and 
its Ca2+ sensitivity. Moreover, protein carbonylation 
also increased the Ca2+-independent passive force, 
which suggested a potential mechanism for the 
pathologic regulation of myocardial stiffness. 
 
2. Methods 
 
2.1 Human left ventricular tissue samples 
 
Human donor hearts from four general organ-donor 
patients (41- and 46-year-old women, and 53- and 
57-year-old men) were stored at -80 °C. The cause of 
death was cerebral aneurysm rupture or 
hemorrhagic stroke. The donors did not reveal any 
sign of cardiac abnormalities and had not received 
any medication apart from short-term dopamine, 
noradrenaline and mannisol. The experiments on 
human tissues complied with the Helsinki 
Declaration of the World Medical Association and 
were approved by the Hungarian Ministry of 
Health (No. 323-8/2005-1018EKU). 
 
2.2 Determination of myofilament protein carbonylation 
by oxyblot assay 
 
The carbonyl group content of the myofilament 
proteins was determined with an oxyblot protein 
oxidation detection kit (Millipore, Billerica, MA, 
USA). Triton-permeabilized (0.5% Triton-X 100; 
Sigma-Aldrich, St. Louis, MO, USA) cardiomyocytes 
were treated at room temperature with isolating 
solution (control) or with isolating solution 
supplemented with Fenton reagents (containing 50 
µM FeSO4, 6 mM ascorbic acid and various 
concentrations of H2O2 in the range 0-105 µM; all 
chemicals from Sigma-Aldrich, St. Louis, MO, USA). 
After removal of the reagents by washing, the 
myocardial tissue samples were dissolved in a 
modified radio-immunoprecipitation assay solution 
[pH=8.0; 50 mM Tris-HCl, 150 mM NaCl, 1% Igepal, 
0.5% sodium deoxycholate, 6% sodium 
dodecylsulfate (SDS), 1% protease inhibitor cocktail; 
all components from Sigma-Aldrich, St. Louis, MO, 
USA]. Protein concentrations were determined by 
dot blot, using bovine serum albumin (BSA; Sigma 
Aldrich, St. Louis, MO, USA) as standard. The 
concentrations of the protein homogenates were 
adjusted to 3 mg/ml. The subsequent steps were 
performed according to the manufacturer’s 
recommendations. Briefly, the carbonyl groups 
were derivatized to 2,4-dinitrophenylhydrazone 
through reaction with 2,4-dinitrophenylhydrazine. 
Polyacrylamide gel electrophoresis (PAGE) was 
used to separate the derivatized protein samples. 
After Western immunoblotting, the membranes 
were probed with the antibodies included in the kit, 
diluted in phosphate-buffered saline containing 
0.1% Tween-20 supplemented with 1% BSA. The 
bands were visualized by the enhanced 
chemiluminescence method and evaluated by 
Image J software (free software from the National 
Institutes of Health, Bethesda, MD, USA). Band 
intensities were normalized for the amount of actin 
visualized by Sypro Ruby protein blot staining (Life 
Technologies, Carlsbad, CA, USA). All assays were 
performed in triplicates. Data are shown in relative 
units (carbonylation index; CI), compared to the 
control. 
 
2.3 Determination of myofilament protein sulfhydryl 
group oxidation 
 
Sulfhydryl (SH) content was evaluated by the 
Ellman reaction. Permeabilized cardiomyocytes 
were treated at room temperature with Fenton 
reagent solution (containing ascorbic acid, iron and 
H2O2 in the range 0-105 µM), or with 2.5 mM 2,2’-
dithiodipyridine (DTDP; Sigma-Aldrich, St. Louis, 
MO, USA) as a positive control, or with 10 mM 
dithiothreitol (DTT; Sigma-Aldrich, St. Louis, MO, 
USA) as a negative control. SH content was 
determined by incubation with the SH-sensitive 
Ellman reagent [5,5’-dithio-bis(2-nitrobenzoic acid); 
Sigma-Aldrich, St. Louis, MO, USA] for 15 min at 
room temperature. The absorbance of the solutions 
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was measured at 405 nm, using a NOVOstar 
microplate reader, and was considered to be 
proportional to the SH content. The SH content was 
determined by means of calibration curves 
(standard: N-acetyl-L-cysteine; Sigma-Aldrich, St. 
Louis, MO, USA) fitted to a single exponential, and 
the SH contents of the myocardial samples were 
calculated for 1 mg protein. Protein concentration 
was assessed by using BSA as a standard. The 
experiments were performed in triplicates. 
 
2.4  Force measurements in permeabilized cardiomyocyte 
preparations 
 
Frozen human left ventricular myocardial tissue 
samples were mechanically disrupted in isolating 
solution (1 mM MgCl2, 100 mM KCl, 2 mM EGTA, 4 
mM ATP, 10 mM imidazole, pH 7.0), and thereafter 
permeabilization was performed with 0.5% Triton-X 
100 detergent. Single permeabilized cardiomyocytes 
were attached to two stainless steel insect needles, 
which were connected to a force transducer 
(SensoNor, Horten, Norway) and to an 
electromagnetic motor (Aurora Scientific Inc., 
Aurora, Canada). Isometric force measurements 
were performed during repeated activation–
relaxation cycles at 15 °C at a sarcomere length (SL) 
of 2.3 µm using relaxing [10 mM N,N-Bis(2-
hydroxyethyl)-2-aminoethanesulfonic acid, 37.11 
KCl, 6.41 mM MgCl2, 7 mM EGTA, 6.94 mM ATP, 15 
mM creatine phosphate, pH 7.2] and activating (the 
same components apart from containing CaEGTA 
instead of EGTA) solutions. The pCa, i.e. –log10 
[Ca2+], of the relaxing solution was 9, and that of the 
activating solution was 4.75. All solutions contained 
protease inhibitors: 0.5 mM phenylmethylsulfonyl 
fluoride, 40 µM leupeptin and 10 µM E-64. All 
chemicals were from Sigma-Aldrich, St. Louis, MO, 
USA. 
Transfer of the myocyte from the Ca2+-free 
relaxing solution to the activating solution evoked 
Ca2+ contractures. A quick release–restretch 
maneuver was performed in the activating solution 
during single Ca2+ contractures when the force 
reached the maximal value. Consequently, the force 
dropped from peak level to zero, allowing 
determination of the total force level (Ftotal), and then 
immediately started to redevelop. The rate constant 
of force redevelopment (ktr,max) at pCa 4.75 was 
estimated by fitting the force redevelopment after 
the restretch to a single exponential. The passive 
force level (Fpassive) was then determined by the 
shortening of the original preparation length to 80% 
in relaxing solution. The active isometric force 
(Factive) was calculated by subtracting Fpassive from Ftotal. 
Factive and Fpassive were normalized for the 
cardiomyocyte cross-sectional area, calculated from 
the width and height of the cardiomyocyte.  
The cardiomyocytes (n=6 cardiomyocytes from 
three human hearts) were subsequently incubated at 
room temperature in isolating solution 
supplemented with increasing concentrations of 
Fenton reagent [50 µM FeSO4, 6 mM ascorbic acid 
and gradually increasing concentrations of H2O2: 0-
105 µM; all chemicals from Sigma-Aldrich, St. Louis, 
MO, USA] for 7 minutes for each concentration to 
assess the concentration-dependent effects of Fenton 
reaction-induced protein carbonylation on Factive and 
Fpassive. Identical number of activation–relaxation 
cycles were performed in control cardiomyocytes 
(n=6 cardiomyocytes from three human hearts) 
following incubations in isolating solutions without 
Fenton reagents to assess cardiomyocyte run-down 
during repeated activations. Ca2+–force relations 
were assessed both before (control) and after a 
single 7-minute Fenton reaction exposure (50 µM 
FeSO4, 6 mM ascorbic acid, 3*103 µM H2O2) at a SL 
of 2.3 µm (n=6 cardiomyocytes from three human 
hearts) to determine the consequences of protein 
carbonylation on the Ca2+ sensitivity of isometric 
force production (pCa50). The steepness of the Ca2+–
force relation, the Hill coefficient (nHill), is 
characteristic of the interfilament cooperativity 
within the contractile system. Cardiomyocytes were 
exposed to 10 mM DTT in relaxing solution for 30 
minutes at room temperature, subsequently to the 
single Fenton administration, to eliminate the 
mechanical effects of possible reversible 
modifications, e.g. SH oxidation.  
 
2.5 Statistical analysis 
 
The numerical data are given in this work as 
mean values ± SEM. Student t-tests or analysis of 
variance (ANOVA) followed by the Bonferroni post 
hoc test were used to compare the experimental 
groups, with P values <0.05 being considered 
statistically significant. Statistical analyses were 
performed with GraphPad Prism 5.02 software 
(GraphPad Software, Inc., La Jolla, CA, USA). 
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Figure 1. Contractile protein 
carbonylation induced by the 
Fenton reaction in 
permeabilized human 
cardiomyocytes. Equal 
amounts of human myocardial 
proteins were subjected to SDS-
PAGE following in vitro 
incubation in the presence of 
Fenton reagents, and 
subsequently developed with 
the protein carbonyl-sensitive 
oxyblot method. Fenton 
reaction resulted in the 
significant carbonylation of 
myocardial proteins, as 
evidenced by a representative 
result revealing increasing 
signal intensities with 
increasing concentrations of 
H2O2 in the Fenton mixture (a) 
and the total carbonylation 
levels of all myocardial 
proteins (b). The sensitivity for 
carbonylation (c) was different 
for the proteins identified at 
molecular masses (MW) of: 
MHC (myosin heavy chain, 200 
kDa), MyBPC (myosin binding 
protein C, 140 kDa); α-actinin 
(100 kDa), desmin (55 kDa), 
actin (43 kDa), MLC-1 (myosin 
light chain-1, 20 kDa). * P<0.05 
vs. Control. Explanation of the 
nomenclature: as an example 
Fenton 103 indicates Fenton 
solution containing 103 µM 
H2O2. 
3. Results 
 
3.1 Myofilament protein carbonylation in human 
cardiomyocytes 
 
Fenton treatment with increasing H2O2 
concentrations increased carbonyl group formation 
in the proteins of the human permeabilized 
cardiomyocytes, as reflected by the gradual increase 
seen in the signal intensities in oxyblot assays 
(Figure 1a). The approximate molecular masses of 
the affected abundant proteins (i.e. at 20, 43, 55, 100, 
140 and 200 kDa) corresponded to those of 
myofilament proteins: myosin light chain-1 (MLC-1, 
20 kDa), actin (43 kDa), desmin (55 kDa), α-actinin 
(100 kDa), myosin binding protein C (MyBPC, 140 
kDa) and myosin heavy chain (MHC, 200 kDa), 
respectively. The mean levels of carbonylation for 
all myocardial proteins (expressed in relative units 
as the CI, the CI for the control being taken as 1.0 
and intensities of all of the other bands being 
compared with that of the control band on the same 
gel) suggested a sigmoidal H2O2 concentration 
dependence (in the Fenton mixture) with an 
apparent saturation around 105 µM H2O2 (Control: 
1±0.05; 0 µM H2O2: 1.05±0.06; 100 µM H2O2: 
1.08±0.06; 102 µM H2O2: 1.27±0.07; 103 µM H2O2: 
1.86±0.11; 3*103 µM H2O2: 3.38±0.32; 3*104 µM H2O2: 
6.22±0.75; 105 µM H2O2: 6.80±0.82; in CI units; Figure 
1b). The relative protein carbonylation appeared to 
be higher than the average for the proteins at the 
molecular masses of MLC-1, MyBPC, and α-actinin, 
whereas it was less than the average for the proteins 
at the molecular masses of desmin, actin, and MHC 
(Figure 1c). 
 
3.2 High dose Fenton reagent oxidizes the sulfhydryl 
groups of myocardial proteins 
 
To investigate whether exposure of the 
cardiomyocytes to Fenton reaction-derived radicals 
led not only to protein carbonylation, but also to SH 
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Figure 3. Incubation in Fenton solution did not evoke microscopic alterations, but decreased Factive. The Fenton 
reaction did not induce light-microscopically visible structural changes in the cardiomyocytes mounted on the 
mechanical force-measuring set-up (a). The carbonylation induced by the Fenton mixtures resulted in a gradual 
decline in the Factive of the Fenton-treated cardiomyocytes (n=6) (b). (n: number of cardiomyocytes from three 
human hearts) * P<0.05 vs. initial activation 
group oxidation of the myocardial proteins, the 
Ellman assay was utilized. In vitro exposure to 2.5 
mM DTDP served as a positive control. DTT 
treatment (10 mM) was used to test the reversibility 
of SH group oxidation. Figure 2 illustrates that 
Fenton treatment displayed an SH group oxidizing 
effect (from the control of 471.6±59.1 µM/mg protein 
to 201.6±21.4 µM/mg protein), which was significant 
at the highest applied H2O2 concentration (Fenton 
105), but not at the lower concentrations (Fenton 0: 
408.1±40.5 µM/mg protein; and at Fenton 3*103: 
310.4±36.1 µM/mg protein). DTDP treatment 
decreased the SH group content even further (to 
83.1±15.3 µM/mg protein), whereas the SH group 
oxidation was reversed by the antioxidant DTT 
treatment both after Fenton treatment and after 
DTDP application (599.3±102.1 µM/mg protein and 
621.2±107.3 µM/mg protein, respectively). Hence, 
not only the relative level of protein carbonyls, but 
also the level of SH groups was a function of the 
Fenton treatment.  
 
3.3 Protein carbonylation reduces the isometric 
contractile force in a concentration-dependent 
manner 
 
To investigate the mechanical consequences of 
myofilament protein carbonylation, isolated 
permeabilized human cardiomyocytes (n=6) were 
treated with Fenton solution in a mechanical force 
measurement set-up similarly as in the biochemical 
assays. The concentration-dependent effects of the 
Fenton reaction on isometric active force production 
were first obtained (Figure 3b). Time control 
experiments (n=6) were also performed to evaluate 
the run-down of cardiomyocyte contractile 
performance resulting in a non-significant decrease 
in relative force to 87.4±2.8% following 10 repeated 
activations. As reflected by the microscopic 
Figure 2. Radicals produced by the Fenton reaction 
oxidize protein sulfhydryl (SH) groups. The Fenton 
reaction at 105 µM H2O2 concentration induced SH 
oxidation as evidenced by the relative SH group content 
in Ellman assays. SH oxidation was prevented by the 
antioxidant dithiothreitol (DTT, 10 mM). 2,2’-
dithiodipyridine (DTDP) and DTT after DTDP were used 
as internal controls. * P<0.05 vs. Control; # P<0.05 vs. 
before DTT 
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Figure 4. The effects of carbonylation on the mechanical properties of human cardiomyocytes. The Ca2+–
force relations (a) and the mean pCa50 values (b) illustrate that exposure to the Fenton solution containing 
3*103 µM H2O2 resulted in a decreased Ca2+ sensitivity of force production. Carbonylation induced a decrease 
in Factive (c) and an increase in Fpassive (d). DTT treatment had no effects on either mechanical parameter. Error 
bars are indicated where larger than symbol size. n=6 cardiomyocytes from three human hearts * P<0.05 vs. 
Control 
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photographs, no major structural changes were seen 
at any time throughout the experiments (Figure 3a). 
Nevertheless, a gradual decline in the Ca2+-
dependent active force (Factive) was observed in 
parallel with increasing oxidative stress [i.e. with 
increasing concentrations of H2O2, in the presence of 
constant iron(II) and ascorbic acid concentrations 
(Control: 100%; Fenton 0: 98.9±3.3%; Fenton 100: 
95±3.9%; Fenton 102: 89.1±3.7%; Fenton 103: 
68.3±4.1%; Fenton 3*103: 54.9±4.7%; Fenton 104: 
36±3.7%; Fenton 3*104: 3.5±1.6%; Fenton 105: 
0.3±0.1%; in relative units, Figure 3b)]. This decrease 
in Factive reflected the increase in the CI for 
myocardial proteins in this H2O2 concentration 
range (Figure 1b).  
 
3.4 Impaired contractile performance as a result of 
myofilament carbonylation in human cardiomyocytes 
 
A group of isolated human cardiomyocytes (n=6) 
was subjected to a single exposure to Fenton 
solution containing 3*103 µM H2O2 to test its effects 
on the Ca2+ sensitivity of force production (pCa50), 
Factive and Fpassive. Subsequent DTT exposures were 
used to test the reversibility, and to estimate the SH-
sensitive components of the observed mechanical 
changes. A clear reduction in the Ca2+ sensitivity of 
force production was observed following incubation 
in the presence of this Fenton solution, which was 
reflected by the rightward shift of the Ca2+–force 
relation and a significant decrease in pCa50 
[pCa50(Control): 5.74±0.01; pCa50(Fenton): 5.65±0.01; 
P<0.05]. Besides the decreased Ca2+ sensitivity of 
force production (Figure 4a,b), a reduced Factive 
(Figure 4c) and an increased Fpassive (Figure 4d) were 
detected [Factive(Control): 11.39±1.63 kN/m2; 
Factive(Fenton): 8.66±1.06 kN/m2; Fpassive(Control): 
1.72±0.21 kN/m2; Fpassive(Fenton): 2.33±0.22 kN/m2]. 
The rate constant of tension redevelopment (ktr,max) 
and the Hill coefficient (nHill) were not affected by 
the in vitro induced carbonylation [ktr,max(Control): 
0.68±0.06 1/sec; ktr,max(Fenton): 0.57±0.02 1/sec; 
nHill(Control): 2.42±0.05; nHill(Fenton): 2.31±0.06]. 
Subsequent DTT treatment affected none of these 
parameters [pCa50(DTT): 5.63±0.01; Factive(DTT): 
7.14±1.1 kN/m2; Fpassive(DTT): 2.44±0.28 kN/m2; 
ktr,max(DTT): 0.55±0.07 1/sec; nHill(DTT): 2.43±0.1; 
P>0.05 vs. Fenton; P<0.05 vs. Control].  
 
4. Discussion 
 
As far as we are aware, this is the first reported 
study of the direct effects of protein carbonylation 
on the contractile function of human 
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cardiomyocytes. To this end, Fenton chemistry was 
used to produce hydroxyl radicals and to induce 
protein carbonylation in permeabilized left 
ventricular cardiomyocytes in vitro, an approach 
which allowed the characterization of the 
relationship between the level of myofilament 
carbonylation and quantitative indices of isometric 
force production. Interestingly, the carbonylation-
evoked mechanical dysfunction was not 
accompanied by visible microscopic alterations in 
the cardiomyocyte structure. Hence, our results 
suggest that myofilament protein carbonylation 
disturbs the fine regulation of cardiomyocyte 
contractility. 
Several different types of post-translational 
oxidative contractile protein modifications (e.g. SH 
group oxidation, protein nitration, protein 
carbonylation, etc.) have been reported as possible 
mediators of a contractile dysfunction during 
oxidative stress in the heart [19]. The mechanical 
consequences have also been elucidated for some, 
but not all of the above protein changes. Superoxide 
anion exposure, for instance reduced Factive in a 
concentration-dependent manner, but had no effect 
on the Ca2+ sensitivity of force production in the rat 
right ventricular trabeculae [20]. Similarly to 
superoxide anion, peroxynitrite-induced protein 
nitration impaired the contractile function in 
isolated human and rat cardiomyocytes [21,22]. A 
high degree of myofilament SH oxidation was 
earlier demonstrated to decrease not only 
myofilament force production, but also its Ca2+ 
sensitivity in permeabilized human cardiomyocytes 
[23]. However, practically no information is 
currently available as concerns the mechanical 
effects of contractile protein carbonylation in human 
cardiomyocytes. 
In a rat model of right heart failure, serotonin-
mediated right ventricular protein carbonylation 
was considered to be an important 
pathophysiologic factor [24]. Moreover, myofibrillar 
actin carbonylation was recognized both after 
experimental ischemia–reperfusion and following 
H2O2 exposure in isolated rat hearts [16]. The same 
investigators also reported on the carbonylation of 
the thin myofilament protein, tropomyosin in 
porcine and canine hearts in response to coronary 
microembolizations, the degree of tropomyosin 
oxidation correlating with the contractile 
dysfunction observed [17]. Further, the 
carbonylation of MyBPC, MHC and actin has been 
implicated in post-ischemic murine models [25,26].  
Bagatini et al. reported an increase in the 
serum protein carbonylation of human patients with 
acute myocardial infarction and in others with risk 
factors for acute myocardial infarction [27]. Elevated 
plasma protein carbonyl levels were likewise 
detected during coronary artery bypass grafting, 
both after the initiation of ischemia and during the 
reperfusion period [28]. The carbonylation of 
tropomyosin has been correlated with the 
contractile impairment in human heart failure, and 
this type of protein modification has also been 
regarded as a marker of severe oxidative stress [18]. 
Thus, myofilament protein carbonylation appears to 
be central in the pathogenesis of the myocardial 
dysfunction during oxidative stress. 
In the present study, the effects of contractile 
protein carbonylation were provoked in vitro by a 
hydroxyl radical-generating Fenton reaction in 
human permeabilized cardiomyocytes. This reaction 
is observed in failing cardiac myocytes [29] and 
during ischemia–reperfusion injury [30], and the 
Fenton reaction is widely employed to produce 
hydroxyl radicals by the reaction of iron(II) and 
H2O2 for in vitro experiments [13,31,32]. The 
advantage of the combination of this technique with 
the study of isolated, permeabilized cardiomyocytes 
is that it excludes interference with membrane 
components, intracellular organelles and elements 
of the Ca2+ homeostasis [33].  
Oxidative protein modifications other than 
protein carbonylation cannot be excluded for 
hydroxyl radical exposures [13,34]. In our studies, 
we paid specific attention to SH oxidation, and 
observed that a significant level of SH oxidation 
could be detected only when an extremely high 
concentration of H2O2 was applied in the Fenton 
system. Moreover, despite the SH oxidation, DTT 
did not prevent the alterations in the cardiomyocyte 
mechanics, suggesting that at the lower H2O2 
concentrations the underlying molecular 
mechanism is not related to SH oxidation. On the 
other hand, the contractile proteins of the human 
cardiomyocytes (similarly to those in animal hearts) 
proved to be highly sensitive to carbonylation. 
Exposure to the increasing concentrations of H2O2 in 
the Fenton reagent enhanced the level of protein 
carbonylation and reduced the maximal isometric 
force in a graded fashion. It is unlikely that the 
highest concentrations of radicals produced by this 
method are present under physiological conditions 
[35]. Nonetheless, free radical concentrations might 
reach levels sufficiently high to provoke relevant 
levels of protein carbonylation in vivo in diffusion-
limited compartments. Hydroxyl radicals are highly 
reactive, acting immediately on the first cell 
components they meet [35]. In our in vitro study, 
hydroxyl radicals were generated in the direct 
vicinity of cardiomyocytes and modified a number 
of myofilament proteins. Collectively, it is uncertain 
whether the carbonylation of a selected single 
protein alone or that of a group of proteins in 
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combination was responsible for the observed 
mechanical changes. 
Oxidative protein modifications resulting in a 
gain or loss of function or targeted degradation may 
lead to impaired cellular functions or the 
accumulation of modified proteins [36]. These 
changes can dysregulate the contractile protein 
machinery of cardiomyocytes during conditions of 
oxidative stress. In our present experiments, protein 
carbonylation decreased active force production and 
its Ca2+ sensitivity similarly as observed earlier in 
the residual cardiomyocytes of the infarcted zone in 
post-infarction murine hearts [26]. These changes 
may contribute to the development of weaker 
myocardial contractions and hence to a systolic 
dysfunction. We also report here that myofilament 
protein carbonylation increases the Ca2+-
independent passive force, thereby implicating a 
potential molecular mechanism for increased 
cardiomyocyte stiffness in a diastolic dysfunction 
for the human heart [37]. 
Importantly, a reduced Ca2+ responsiveness 
and/or contractile dysfunction are frequently 
referred to in clinical conditions in association with 
oxidative stress. In a post-infarction murine model, 
left ventricular remodeling and dysfunction were 
prevented by the hydroxyl radical scavenger 
dimethylthiourea [38]. Moreover, myocardial 
stunning is also characterized by excessive oxidative 
stress and reduced myofilament Ca2+ sensitivity 
[39,40]. The present results suggest that 
myofilament carbonylation may be regarded as a 
potential link between myofilament oxidation and 
the contractile dysfunction in the above conditions. 
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